ModelEdge

Pear Therapeutics Inc.

Filing Type	10-K
Filing Date	3/28/2022
Updated	3/28/22, 12:22 PM

Filing

Earnings Release

Exhibits

EX-4.4EX-4.4 DESCRIPTION OF SECURITIES REGISTERED

EX-10.33EX-10.33 2ND AMENDMENT TO OFFICE LEASE AGREEMENT, DATED AS OF DECEMBER 30, 2020

EX-10.34EX-10.34 THIRD AMENDMENT TO CREDIT AGREEMENT AND GUARANTY, MARCH 25, 2022

EX-10.35EX-10.35

EX-10.36EX-10.36 A&R INTERCOMPANY SUBORDINATION AGREEMENT, MARCH 25, 2022

EX-23.1EX-23.1 CONSENT OF DELOITTE & TOUCHE LLP

EX-31.1EX-31.1 CERTIFICATION OF THE CEO PURSUANT TO RULE 13A-14(A) OR 15D-14(A)

EX-31.2EX-31.2 CERTIFICATION OF THE CFO PURSUANT TO RULE 13A-14(A) OR 15D-14(A)

EX-32.1EX-32.1 CERTIFICATION OF CEO & CFO PURSUANT TO SECTION 906